But that's not necessarily true, and the statement was regarding R&D not general income. The larger income in America part can also be questioned, particularly

But that's not necessarily true, and the statement was regarding R&D not general income. The larger income in America part can also be questioned, particularly when the revenue in the US comes also comes a large cost of marketing - which some reports say exceed the cost of R&D. The US is also one of the few nations that allows that expenditure. It seems like we're just paying to much and funding a lot of marketing and doing nothing for R&D of drugs.